Top 10 Restaurants Startup Investors in Switzerland in July 2025

Last updated: Jul 2025 A list of 10 angel investors and VC (Venture Capital) funds that invest in Restaurants startups based in Switzerland. We rank investors based on the number of investments they made in Restaurants companies from Switzerland. We update this investor list every month.

Top 10 Restaurants Startup Investors in Switzerland in July 2025

Investor	Restaurants Switzerland investments
Filippo Catalano	2
3wVentures	2
Eugenio Cassiano	1
Nikolaus Wein	1
4See Ventures	1
Prediction Capital	1
Innosuisse	1
Verve Ventures	1
Serge Schoen	1
Luigi Matrone	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Filippo Catalano is the Chief Information and Digital Officer of Mondelez International. He previously worked at Nestlé as a Group CIO. Filippo Catalano attended The Faculty of Engineering at Lund University.

Investment focus

SaaS, Mobile, Software
Seed
Switzerland

Portfolio highlights

PowerAPI — Foodetective enables F&B businesses to integrate & manage their entire tech stack from a single OS & platform. Increasing online revenues and visibility as well as removing all operational & administrative tasks. Our vision is to become the intelligent OS & interface of the F&B industry.

3wVentures provides seed money and venture capital to international internet startups. As they focus on early stage projects and prototypes, our investments and co-investments target a volume of up to USD 250,000.

Investment focus

Software, Health Care, Information Technology
Seed, Angel, Series A
Switzerland, Spain, Austria

Portfolio highlights

Abionic — Abionic SA is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology. As a spin-off from EPFL (Swiss Federal Institute of Technology Lausanne, Switzerland), Abionic uses these highly advanced technologies to provide the medical profession with a novel diagnostic tool designed to give patients personal allergyprofiles. Abionic aims to become an important international player in the field of personalized medicine, in particular in allergy detection.Abionic SA is a certified ISO 9001/13485 company, including research, development and commercialization of in vitro diagnostic devices for allergies detection. The standard ISO 13485 specifies requirements for a quality management system where an organization has to demonstrate its ability to provide medical devices and related services that consistently meet customer and regulatory requirements.Abionic SA is a privately owned high-tech company and is strongly supported by the Swiss Federal Institute of Technology of Lausanne (EPFL), The Canton of Vaud and Venturelab.Abionic was founded by former scientists from the biomedical optics laboratory (LOB) at EPFL. Its headquarters are located in Lausanne, Switzerland.Abionic appreciates the support it has received from:
GUURU — GUURU's Community Solution enables trustworthy and authentic live conversations between shoppers and your customer community.
Pregnolia — Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.

Eugenio Cassiano

Investment focus

SaaS, Mobile, Software
Seed
Switzerland

Portfolio highlights

PowerAPI — Foodetective enables F&B businesses to integrate & manage their entire tech stack from a single OS & platform. Increasing online revenues and visibility as well as removing all operational & administrative tasks. Our vision is to become the intelligent OS & interface of the F&B industry.

Nikolaus Wein

Investment focus

Software, Restaurants, Food and Beverage
Funding Round
Switzerland

Portfolio highlights

Lunchgate — Lunchgate is a restaurant rediscovery website where customers can look at menus, reserve tables, and check 360-degree views of restaurant interiors. It is based in Zurich, Switzerland.

4see ventures is a Swiss venture capital firm investing in exceptional entrepreneurs who are defining the future. We focus on real game-changers in their industries who are having a positive impact on society.

Investment focus

Medical, Health Care, Security
Seed, Series C
Switzerland, Israel

Portfolio highlights

CYSEC — Secure your sensitive data in the cloud and in the edge with ARCA Trusted OS and open the door to innovation with confidential computing.
PowerAPI — Foodetective enables F&B businesses to integrate & manage their entire tech stack from a single OS & platform. Increasing online revenues and visibility as well as removing all operational & administrative tasks. Our vision is to become the intelligent OS & interface of the F&B industry.
HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.

Prediction Capital is an early-stage ConsumerTech and FinTech investment firm. We are a young and dynamic team, acting eye-to-eye with our founders.

Investment focus

Software, SaaS, EdTech
Seed, Pre-Seed
Germany, Switzerland

Portfolio highlights

PowerAPI — Foodetective enables F&B businesses to integrate & manage their entire tech stack from a single OS & platform. Increasing online revenues and visibility as well as removing all operational & administrative tasks. Our vision is to become the intelligent OS & interface of the F&B industry.
Bling.de — The pocket money card and app that empowers children & teens to be money-smart. Safe, simple and educational.
House Of Change — House of Change is building the Sustainability Copilot to democratise sustainability expertise. Get on the waitlist for the best AI in sustainability.

Innosuisse’s role is to promote science-based innovation in the interests of industry and society in Switzerland.

Investment focus

Health Care, Biotechnology, Medical Device
Grant, Pre-Seed, Seed
Switzerland, United States, United Kingdom

Portfolio highlights

Manukai — At Manukai, our mission is to bridge the gap between design and production.
Vestir AI — We're revolutionizing online clothes shopping through AI-powered digital avatar technology. In 3D, in video, with photo-likeness & garment movement - further than anyone has attempted before. Our mission is to recreate the in-store fitting room experience online, changing online shopping forever.
Ymmunobio — At Ymmunobio, our research is based on our deep understanding of immuno-oncology and precision cancer treatments. We leverage our profound knowledge of biologics, focusing on unique and first-in-class targets while selecting the optimal approach to developing transformative therapeutics across cancer indications.

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Investment focus

Health Care, Software, Biotechnology
Series A, Seed, Series B
Switzerland, France, Germany

Portfolio highlights

Metafuels — Our breakthrough sustainable aviation fuel (SAF) technology, aerobrew™, will make affordable net-zero aviation a reality. The technology is innovative, highly scaleable and able to tap into future global renewable energy systems efficiently. Starting from renewable feedstocks including green hydrogen, driven by renewable electricity, andsustainably sourced CO2, for example from direct air capture, aerobrew™ provides an efficient route to large-scale production of e-kerosene, overcoming the scale up challenges and high costs of alternative e-fuels technologies. aerobrew™ is also compatible with the biogenic route whereby the carbon required for the process is derived from renewable and sustainable cellulosic biomass which, does not compete with the food chain (wood, miscanthus, etc.). With a high carbon conversion, high selectivity and a high overall SAF yield, aerobrew™ leads to attractive production economics and cost leadership. With a rapidly growing demand for SAF, aerobrew™ stands to contribute significantly to the decarbonisation of global aviation and to support the achievement of net zero 2050 targets.
Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
Orakl Oncology — Cultivated with love by the Orakl team.

Founding Partner and Chairman of Ambrosia Investments, a Founding Partner and Chairman of EightStone Private Limited and EightStone Family Office, Member of the Board of Cofco International Limited, Director of Itsu Limited, and Member of the Executive Board of the MIT Business School (Sloan). Served as the Chief Executive Officer of Louis DreyfusCompany from 2005 to mid 2013 and as Executive Chairman of Louis Dreyfus Company Holdings B.V.